Business / Finance

RSS

Sphere Fluidics announces closure of $2 million (circa £1.5 million) investment round

Sphere Fluidics announced today that is has closed a $2 million (circa £1.5 million) investment round.

From Society for Laboratory Automation and Screening (SLAS) 30 Jan 2019

QPS launches new brand identity to support continued global expansion

The year 2019 marks 24 years of growth for QPS, LLC, a leading global CRO focused on bioanalytics and clinical trials that accelerate pharmaceutical breakthroughs.

16 Jan 2019

Clinigen, Accord Healthcare extend exclusive European clinical trial supply agreement

Clinigen Group plc, the global pharmaceutical and services company, announces that its Clinical Trial Service business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also offering pharma companies an ‘on demand’ service to Accord’s products, a first for the industry.

From Clinigen Group 11 Jan 2019

Excelitas acquires Axsun Technologies

Excelitas Technologies Corp., a global technology leader focused on delivering innovative, customized photonic solutions, has completed the acquisition of Axsun Technologies.

From Excelitas Technologies 3 Jan 2019

ZEISS achieves record-breaking revenue and earnings

The ZEISS Group is continuing its growth trajectory: Revenue increased by nine percent to EUR 5.817 billion (previous year: EUR 5.348 billion).

From Carl Zeiss AG 19 Dec 2018

Butantan Institute signs collaboration agreement with MSD to develop dengue vaccines

On Wednesday, December 12, 2018, Brazil's Butantan Institute signed a collaboration agreement with Merck Sharp & Dohme (MSD) to develop dengue vaccines.

12 Dec 2018

New collaborative partnership in quest of novel antibiotics

The Global Antibiotic Research and Development Partnership, Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen components of Eisai and Takeda's chemical libraries.

12 Dec 2018

Subsidiaries of Community Health Systems sign definitive agreement to sell four South Carolina hospitals

Community Health Systems, Inc. announced today that subsidiaries of the Company have signed a definitive agreement to sell four South Carolina hospitals - 82-bed Chester Regional Medical Center in Chester, 225-bed Springs Memorial Hospital in Lancaster, 396-bed Carolinas Hospital System in Florence, and 124-bed Carolinas Hospital System - Marion in Mullins - along with related businesses, including physician clinic operations and outpatient services, to the Medical University Hospital Authority in Charleston, S.C.

20 Nov 2018

Nicoya designate the Institute for Stem Cell Biology and Regenerative Medicine as the OpenSPR Centre of Excellence

Currently in India, there are over 200,000 researchers working on numerous applications to better understand diseases and advance drug discovery. To support their discoveries, we are thrilled to announce the opening of the OpenSPR Centre of Excellence in Bangalore, India!

From Nicoya Lifesciences 15 Nov 2018

Empowering the NHS through Industry Partnerships

An interview with Cara Afzal and Lee-Ann Farrell discussing the importance of industry partnerships with the NHS, and how Janssen are working to improve dementia care for Manchester and hematology services for Wales.

13 Nov 2018

Illumina signs agreement to acquire Pacific Biosciences

Illumina, Inc. and Pacific Biosciences today announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction.

2 Nov 2018

RTI Surgical enters into definitive agreement to acquire Paradigm Spine

RTI Surgical, Inc., a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments.

2 Nov 2018

Reliable Respiratory announces acquisition of Attleboro Area Medical Equipment

Reliable Respiratory, one of New England's leading home respiratory and specialty medical equipment providers, today announced the acquisition of Attleboro Area Medical Equipment of Attleboro, Mass.

17 Oct 2018

Themis, Max-Planck-Innovation sign license agreement to develop and commercialize oncolytic virotherapies

Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.

11 Oct 2018

Apollo Endosurgery to distribute cold Ensizor Flexible Endoscopic Scissors in select markets

Apollo Endosurgery, Inc., a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor® Flexible Endoscopic Scissors in the United States, Europe, and select other markets.

9 Oct 2018

Blackstone to acquire leading life sciences investment firm, Clarus

Blackstone today announced that it has agreed to acquire Clarus, a leading global life sciences investment firm that has raised $2.6 billion since its founding. Clarus, with offices in the life sciences hubs of Boston and San Francisco, is focused on funding growth-stage investments, often in partnership with major biopharmaceutical companies through R&D collaborations.

5 Oct 2018

Einstein Healthcare Network and Jefferson enter into binding Definitive Agreement

Einstein Healthcare Network and Jefferson (Philadelphia University + Thomas Jefferson University) have entered into a binding Definitive Agreement, legally binding the ideas and commitments described in the Letter of Intent, which the two organizations signed in March.

17 Sep 2018

Johnson & Johnson Medical acquires EIT to enhance interbody implant portfolio

Johnson & Johnson Medical Devices Companies, through its subsidiary Johnson & Johnson Medical GmbH, announced today the acquisition of Emerging Implant Technologies GmbH, a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, based in Wurmlingen, Germany.

From Johnson & Johnson 14 Sep 2018

Founder and Chairman of MR Solutions shortlisted for 2018 NatWest Great British Entrepreneur Awards

Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards.

From MR Solutions 7 Sep 2018

ITL Group announces completion of SMT manufacturing upgrade

Experienced medical device design, development, and manufacturing partner, ITL Group has announced further investment in its on-site PCB manufacturing facility.

From Vitl Life Science Solutions 24 Aug 2018